Cabio Biotech (Wuhan) Co., Ltd

Cabio Biotech (Wuhan) Co., Ltd

CABIO Biotech (Wuhan) Co., Ltd. ("CABIO" for short), established in September 2004, is a high-tech enterprise underpinned by biotechnology and the first company listed on the Science and Technology Innovation Board (stock code: 688089) in Hubei Province. 

After nearly two decades of development, CABIO has built a complete technology transfer platform of industry chain, incorporating directive breeding of microbial strain, fine regulation of cell, high-efficient separation & purification, preparation, directional transmission, high-throughput detection & analysis, among other technology modules. We provide quality functional ingredients and creative solutions to developers of nutrition and health foods worldwide. We have achieved the industrialization of arachidonic acid (ARA), docosahexaenoic acid (DHA), β-carotene (BC), N-acetylneuraminic acid and other products. Our products are widely applied in human nutrition, animal nutrition, personal care and other fields.

Insisting on technological innovation as a core motivator, we aim to provide quality products and creative solutions on the field of human nutrition, animal nutrition and personal care, obtain high-quality growth and sustainable development, and create long-term values for customers, employees, shareholders and other stakeholders.

Latest content from Cabio Biotech (Wuhan) Co., Ltd

N-acetylneuraminic acid keeps your skin  healthy-looking with revitalizing

Paid for and content provided by Cabio Biotech (Wuhan) Co., Ltd

N-acetylneuraminic acid keeps skin looking healthy and revitalized

N-acetylneuraminic acid is a new ingredient that can satisfy consumer demand for natural and safety; it can eliminate the active oxygen free radicals produced in the human body to play an anti-oxidant and protective role.